The Epstein Barr-Virus is the only known virus, which is able to infect and immortalize human B cellswith high efficiency in vitro. We have constructed EBV-derived recombinant plasmids ("mini-EBV") which are able to immortalize primary human Blymphocytes in vitro by transfection. These plasmids carry all the viral genes necessary for their permanent intracellular maintenance (latency), but lack most of the genes for the productive lytic lifespan. Therefore, no virus is produced and secreted. Mini-EBV's have been constructed in E.Coli using the chromosomal building technique described by O'Connor et al. (Science 244: 1307(Science 244: , 1989 Further deletions of indispensable genes from the backbone of El-deleted adenoviral vectors should decrease their immunogenicity and increase their biosafety. In this respect, a way to cripple ihe virus is to silence the E4 locus, a region which regulates the infectious cycle at both the transcriptional and post-transcriptional levels of late viral gene expresion. We thus constructed an EIE4 transcomplementing, 293-derived, cell line allowing the generation and propagation of EIE4 doubly-deleted viruses.
been found associated with a characteristic shift in serum IgG subclasses, consisting in a decrease of %IgGl accompanied by an increase of %IgG2 relative to total IgG. In view of the lack of an appropriate serological tumor marker for squamous cell carcinoma of the head and neck (SCC-HN), the diagnostic performance of this new indirect marker was examined. Methods and results: An affinity chromatography technique based on IgG binding to staphylococcus proteins A and G was used for the quantitative determination of IgG, IgGl, and IgG2 in sera from 110 SCC-HN patients and 179 healthy controls. The mean values for %IgGl of patients and controls were 56.4±0.7 and 63.3±0.5, respectively, and differed highly significantly (p<0.0005) from each other. Based on a calculated cut-off (59.9%) the overall diagnostic sensitivity was 70% with a specificity of 75%. In the postoperative monitoring patients with recurrent diseases (n=35) were correctly diagnosed to 83%, and in 15 patients with distant metastases the sensitivity was 87%. Conclusion: The shift in IgG subclasses as tissue non specific marker may be of diagnostic value in initial diagnosis as well as postoperative monitoring of SCC-HN and evaluating distant metastases.
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Epstein-Barr-Virus-derived plasmids as vectors for the generation of cytotoxic T-lymphocytes The Epstein Barr-Virus is the only known virus, which is able to infect and immortalize human B cellswith high efficiency in vitro. We have constructed EBV-derived recombinant plasmids ("mini-EBV") which are able to immortalize primary human Blymphocytes in vitro by transfection. These plasmids carry all the viral genes necessary for their permanent intracellular maintenance (latency), but lack most of the genes for the productive lytic lifespan. Therefore, no virus is produced and secreted. Mini-EBV's have been constructed in E.Coli using the chromosomal building technique described by O'Connor et al. (Science 244: 1307 (Science 244: , 1989 Further deletions of indispensable genes from the backbone of El-deleted adenoviral vectors should decrease their immunogenicity and increase their biosafety. In this respect, a way to cripple ihe virus is to silence the E4 locus, a region which regulates the infectious cycle at both the transcriptional and post-transcriptional levels of late viral gene expresion. We thus constructed an EIE4 transcomplementing, 293-derived, cell line allowing the generation and propagation of EIE4 doubly-deleted viruses.
The biology of these new-generation vectors has been assessed in vitro and in vivo. We conclude that the additional deletion of E4 translates into: -a lower level of viral backbone replication -a drastic shutoff of late viral gene expression -no apparent virus-induced cytotoxicity -an absence of RCA contamination A tail vein injection of 1-galactosidase-encoding EIE4-deleted viruses to C57BL/6 lacZ-trangenic mice leads to a much longer persistance of the viral chromosome in the liver (as a linear, non-methylated entitiy) as compared with an El-deleted virus. Despite the long-term gene delivery, the choice of the promoter used to drive the expression of the transgene is found to be critical; thus, a liver-specific promoter (rat albumin promoter) and a viral promoter (LTR from RSV) lead to a stable and a very transient gene expression, respectively. Our studies demonstrate the feasibility of Ad-mediated durable gene transfer to quiescent tissues. Moreover, the cloning capacity of this vector, which is now extended to 10kb, will facilitate the insertion of regulatory sequences to fine-tune gene expression.
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Non-viral delivery of apoptosis inducing genes p53, Bax and Minor adverse events included pain at injection sites and transient fevers. All patients exhibited an adenovirus typ-5 antibody response (without hypersensitivity or allergic reactions). Clinical activity was evaluable in the 17 nonsresectable patients -2 had objective tumor responses; 6 had stable disease; 9 had progressive disease. Biodistribution of vector was detected by PCR in plasma and serum up to 90 minutes after injections and in voided urine after 1010 PFU and higher doses. We detected transduction in cancer and nonmalignant cells. Tumor-cell transduction occurred despite antibody responses after repeated cycles. Few transduced carcinoma cells exhibited papooses. We detected necrosis and papooses induction in tumor specimens with endogenously mutated or wild-type p53 The prognosis for patients with HNSCC is intimately linked to invasion of adjacent tissues. Thus, inhibition of protease expression in HNSCC via interference with signal transduction pathways may reduce invasive properties and improve survival. Recently, we have shown that a specific ERK-pathway inhibitor ( PD 098059 ) arrests invasion of UM-SCC1 cells in-vitro. We therefore investigated the effect of PD 098059 on this cell line in-vivo. Using a quantitative orthotopic murine model, stepwise invasion of the floor-of-mouth and tongue were evaluated after subcutaneous tumour cell injection. Intralesional administration of PD 098059 using liposomes as a carrier was performed over a 25 day period (every 5 days with 15mM final concentration). Tumor growth arrest and attenuation of tumor invasion occurred in 3 of 4 treated mice; while tumor advanced into the genioglossus muscle in 4 of 5 control mice. Therefore the inhibition of the ERK-signal transduction pathway may become a powerful therapeutic adjuvant in combating invasion of HNSCC.
